Experimental autoimmune encephalomyelitis (EAE) is an animal model that reproduces many of the clinicaland pathological features of multiple sclerosis (MS). While it is well documented that myelin specific T cells,Th1 and Th17 cells are important for the initiation of the disease, the role of B cells and antibodies in thedisease process is not well understood. The development and the progression of EAE, like otherautoimmune diseases, results from the pathogenicity of effector T cells and the negative regulation imposedby regulatory T cells (Tregs). However, the lack of a reliable marker for regulatory T cells has made it difficultto study the interplay between myelin specific effector T cells and regulatory T cells. To study the effect ofantigen specific B cells in the generation of pathogenic T cells, we have established a mouse model(2D2xTH mice) in which both T and B cells are specific for the same myelin protein, myelin oligodendrocyteglycoprotein (MOG). The majority of 2D2xTH mice (about 59%) develop a very severe form of spontaneousEAE within 6 weeks of age that is similar to a sub-form of MS called Devic disease, characterized by thepresence of inflammatory foci restricted to the spinal cord and optic nerve. By gene expression profiling, wehave identified IL-22 as a cytokine differentially upregulated in the spinal cord of mice with Devic disease.We have also generated a Foxp3-EGFP knock-in mouse in order to track CD4+CD25+ Treg cells during thecourse of an ongoing immune response. With the help of l-Ab/MOG35-55 tetramer (developed incollaboration with Kai Wucherpfennig) we are able to track development and effector functions of MOGspecific pathogenic and regulatory T cells. Based on our results, we propose that antigen presentation byMOG-specific B cells generates highly pathogenic T cells and limits the generation and function of MOGspecific CD4+CD25+ regulatory T cells which results in the development of a very severe EAE. We will testwhether: 1) MOG specific B cells participate in disease progression by the secretion of MOG specificpathogenic antibodies and /or by preferential antigen presentation to MOG-specific T cells; 2) T cellsgenerated in the presence of cognate antigen specific B cells are more encephalitogenic and produce moreIL-17 and IL-22; 3) MOG specific B cells limit the expansion and/or function of regulatory T cells responsiblefor keeping pathogenic T cells under check. The role of IL-22 in generating highly pathogenic T cells anddevelopment of Devic-like disease in mice will be evaluated by using IL-22 deficient mice. The proposedstudies will allow us to better characterize the mechanism by which autoantigen specific B cells induceautopathogenic T cells and how they regulate the expansion and function of antigen specific regulatory Tcells. Furthermore, our proposed studies will allow us to study how antigen specific B cells might control thedevelopment of an organ specific T cell mediated autoimmune disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI045757-10
Application #
7433003
Study Section
Special Emphasis Panel (ZAI1-SR-I (S2))
Project Start
2008-09-15
Project End
2013-03-31
Budget Start
2008-09-15
Budget End
2009-08-31
Support Year
10
Fiscal Year
2008
Total Cost
$213,210
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Ito, Yoshinaga; Ashenberg, Orr; Pyrdol, Jason et al. (2018) Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity. J Exp Med 215:2617-2635
Ponath, Gerald; Lincoln, Matthew R; Levine-Ritterman, Maya et al. (2018) Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis. Nat Commun 9:5337
Sumida, Tomokazu; Lincoln, Matthew R; Ukeje, Chinonso M et al. (2018) Activated ?-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity. Nat Immunol 19:1391-1402
Cremasco, Viviana; Astarita, Jillian L; Grauel, Angelo L et al. (2018) FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors. Cancer Immunol Res 6:1472-1485
Meyer Zu Horste, Gerd; Przybylski, Dariusz; Schramm, Markus A et al. (2018) Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1. Immunity 48:556-569.e7
Gee, Marvin H; Sibener, Leah V; Birnbaum, Michael E et al. (2018) Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro. Proc Natl Acad Sci U S A 115:E7369-E7378
Kim, Yong Chan; Zhang, Ai-Hong; Yoon, Jeongheon et al. (2018) Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells. J Autoimmun 92:77-86
Lucca, Liliana E; Hafler, David A (2017) Resisting fatal attraction: a glioma oncometabolite prevents CD8+ T cell recruitment. J Clin Invest 127:1218-1220
Nylander, Alyssa N; Ponath, Gerald D; Axisa, Pierre-Paul et al. (2017) Podoplanin is a negative regulator of Th17 inflammation. JCI Insight 2:
Gierahn, Todd M; Wadsworth 2nd, Marc H; Hughes, Travis K et al. (2017) Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nat Methods 14:395-398

Showing the most recent 10 out of 129 publications